Wegovy® pill (semaglutide)
Oral tabletFrom $500/mo*
A daily oral GLP-1 treatment that helps control appetite and support lasting weight loss.
- A GLP-1 receptor agonist that acts on appetite-regulating pathways
- FDA-approved for chronic weight management in eligible adults
- Prescribed and monitored by a licensed provider
*Billed every 3 months, paid upfront.
Includes provider review · Ships in 3–5 days if prescribed
- Licensed providers
- Free shipping
- US-based pharmacies
Wegovy® is an FDA-approved branded prescription medication dispensed by a licensed pharmacy; it is not compounded. It is prescribed only if a licensed provider determines it is clinically appropriate following an evaluation. Elysium Health is not a clinical provider but contracts with third-party clinical entities with licensed health care providers which provide medical care to individuals that use the Elysium Health platform. Image for illustration only; actual product may vary.
Safety info: Wegovy is used to treat obesity or overweight with weight-related health conditions, along with diet and exercise. It may cause serious side effects, including possible thyroid tumors. Do not use if you or your family have a history of medullary thyroid carcinoma (MTC), or if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). See important safety information.
Why Wegovy® pill
Once-daily oral GLP-1 treatment for weight management
14 % average body weight lost in 64 weeks
Semaglutide is a GLP-1 receptor agonist. It acts on pathways involved in appetite and food intake. The oral form delivers semaglutide as a daily tablet.
In a 64-week clinical trial of adults without type 2 diabetes who had obesity, or overweight with at least one weight-related condition, participants taking Wegovy® 25 mg tablets lost an average of 14% of their body weight, compared with 2.4% for participants taking placebo. All participants followed a reduced-calorie diet and increased physical activity. Individual results vary.
Get startedIllustrative calculator based on published Phase 3 trial averages; it is not a prediction or guarantee of individual results. Individual responses vary; no specific outcomes are guaranteed.
How Wegovy® works
What it does in the body
Semaglutide mimics a hormone your body already makes, under a licensed provider's plan.
Mimics a natural hormone
Semaglutide mimics GLP-1, a hormone involved in appetite and blood sugar regulation.
Supports appetite regulation
It may help you feel fuller and reduce appetite, which supports weight management for some people, with provider guidance and healthy habits.
Provider-guided
Used within a licensed-provider plan alongside diet and activity.
Our medical team
Developed with expert clinicians
From our Chief Medical Officer
The goal of longevity treatment is not simply more years. It is more good years. We built TELI to bring clinical rigor to a space that has too often lacked it, so people can pursue their healthspan with the same confidence they bring to the rest of their medical care.
How The Elysium Longevity Institute works
From intake to your doorstep
- Step 1
Complete your medical intake
Choose your protocol, then share your health history and goals to begin your longevity care.
What your provider needs
- Step 2
Provider review
A licensed provider will review your intake and prescribe a personalized protocol, if appropriate.
Licensed & confidential
- Step 3
Shipped to your door
If prescribed, a licensed partner pharmacy will ship to your door free of charge within 3–5 business days.
Fast, free shipping
- Step 4
Ongoing care
Message your provider any time through your TELI portal.
On-demand support
FAQ
Frequently asked questions
What is Wegovy®?
Wegovy® is an FDA-approved prescription GLP-1 medication containing semaglutide. Along with a reduced-calorie diet and increased physical activity, it is used to help eligible adults with obesity or overweight lose weight and keep it off.
How is the Wegovy® pill different from the Wegovy® injection?
Both contain the same active ingredient, semaglutide. The Wegovy® pill is taken by mouth once daily, while the injection is administered once weekly. Your provider will determine which option is appropriate for you.
How do you take the Wegovy® pill?
Wegovy® is taken once daily on an empty stomach with water. Swallow tablets whole. Do not split, crush, chew or dissolve. Wait at least 30 minutes before eating, drinking, or taking other oral medications. Follow the specific instructions provided by your licensed provider.
What are the side effects of Wegovy®?
Common side effects include nausea, diarrhea, vomiting, constipation, stomach pain, bloating, and indigestion. These effects are often more noticeable when starting treatment or increasing your dose and may improve as your body adjusts. Contact your healthcare provider if any side effect is severe, persistent, or bothersome.
Who shouldn’t take Wegovy®?
Wegovy® should not be used by people with a personal or family history of medullary thyroid carcinoma (MTC), those with multiple endocrine neoplasia syndrome type 2 (MEN 2), or anyone who has had a serious allergic reaction to semaglutide or another ingredient in Wegovy®. Wegovy® is not recommended for people with severe gastroparesis. Tell your provider if you are pregnant or planning to become pregnant, take insulin or certain diabetes medications, or have a history of pancreas, gallbladder, kidney, or diabetic eye problems. Stop at least 2 months before a planned pregnancy. Your provider will review your medical history before prescribing.
Is the Wegovy® pill compounded?
No. Wegovy® is a branded, FDA-approved prescription medication dispensed by a licensed pharmacy.
No specific outcomes are guaranteed; individual results may vary.
Wegovy® is a registered trademark of Novo Nordisk A/S. The Elysium Longevity Institute is not affiliated with, endorsed by, or sponsored by Novo Nordisk.
Ready to start Wegovy® pill (semaglutide)?
Complete your intake online. A licensed provider will review your information and, if eligible, prescribe a personalized plan.
Get started